Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on bone health: Results from the european male ageing study

Calcified Tissue International

Volumn 88, Issue 6, 2011, Pages 503-510

  Pye, Stephen R ^a   Almusalam, Bader ^a   Boonen, Steven ^b,c,p   Vanderschueren, Dirk ^b,c,p   Borghs, Herman ^c,p   Gielen, Evelien ^b,c   Adams, Judith E ^a   Ward, Kate A ^a,d   Bartfai, Gyorgy ^e,p   Casanueva, Felipe F ^f   Finn, Joseph D ^a   Forti, Gianni ^g,p   Giwercman, Aleksander ^h,p   Han, Thang S ⁱ   Huhtaniemi, Ilpo T ^j   Kula, Krzysztof ^k,p   Labrie, Fernand ^l   Lean, Michael E J ^m   Pendleton, Neil ^a   Punab, Margus ^n,p   Silman, Alan J ^o   Wu, Frederick C W ^a   O'Neill, Terence W ^a   Petrone, Luisa ^p   Corona, Giovanni ^p   Slowikowska Hilczer, Jolanta ^p   Walczak Jedrzejowska, Renata ^p   Steer, Philip ^p   Tajar, Abdelouahid ^p   Lee, David ^p   Lage, Mary ^p   Castro, Ana I ^p   Földesi, Imre ^p   Fejes, Imre ^p   Korrovitz, Paul ^p   Jiang, Min ^p   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^e UNIVERSITY OF SZEGED   (Hungary)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g UNIVERSITY OF FLORENCE   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k MEDICAL UNIVERSITY OF LODZ   (Poland)

^l UNIVERSITÉ LAVAL   (Canada)

^m UNIVERSITY OF GLASGOW   (United Kingdom)

ⁿ TARTU UNIVERSITY CLINICS   (Estonia)

^o Arthritis Research UK   (United Kingdom)

^p NONE

more..

Author keywords

Calcaneus quantitative ultrasound; Insulin like growth factor binding protein 1; Insulin like growth factor binding protein 3; Men; Population based

Indexed keywords

ESTRADIOL; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; CALCANEUS; CLINICAL ASSESSMENT TOOL; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; GERIATRIC PATIENT; HUMAN; INTERVIEW; MALE; MIDDLE AGED; MUSCULOSKELETAL SYSTEM PARAMETERS; PHYSICAL ACTIVITY SCALE FOR THE ELDERLY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE STUDY; QUESTIONNAIRE; SMOKING;

EID: 84943015768     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9484-2     Document Type: Article

References (33)

1. Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535-559
2. Fall C, Hindmarsh P, Dennison E et al (1998) Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis. J Clin Endocrinol Metab 83:135-139 (Pubitemid 28498324)
3. Gillberg P, Olofsson H, Mallmin H et al (2002) Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70:22-29 (Pubitemid 36934733)
4. Janssen JA, Burger H, Stolk RP et al (1998) Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138:627-632 (Pubitemid 28313811)
5. Krassas GE, Papadopoulou P, Koliakos G et al (2003) Growth hormone, insulin growth factor-1, and IGF binding protein-3 axis relationship with bone mineral density among healthy men. Arch Androl 49:191-199 (Pubitemid 38223317)
6. Patel MB, Arden NK, Masterson LM et al (2005) Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). Bone 37:833-841
7. Sugimoto T, Nishiyama K, Kuribayashi F et al (1997) Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279 (Pubitemid 27334974)
8. Rucker D, Ezzat S, Diamandi A et al (2004) IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol 60:491-499 (Pubitemid 38482513)
9. Barrett-Connor E, Goodman-Gruen D (1998) Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study. J Bone Miner Res 13:1343-1349 (Pubitemid 28373337)
10. Jehle PM, Jehle DR, Mohan S et al (1998) Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J Endocrinol 159:297-306 (Pubitemid 28520183)
11. Rosen CJ (1999) Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45:1384-1390
12. Conover CA, Bale LK, Clarkson JT et al (1993) Potentiation of insulin-like growth factor action by insulin-like growth factor binding protein-3: studies of underlying mechanism. Growth Regul 3:87-88 (Pubitemid 23131747)
13. Szulc P, Joly-Pharaboz MO, Marchand F et al (2004) Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 74:322-329 (Pubitemid 38480855)
14. Johansson AG, Eriksen EF, Lindh E et al (1997) Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82:2795-2798 (Pubitemid 27385626)
15. Conover CA, Lee PD, Riggs BL et al (1996) Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 137:3295-3301 (Pubitemid 26250178)
16. Jassal SK, von Muhlen D, Barrett-Connor E et al (2005) Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study. Osteoporos Int 16:1948-1954 (Pubitemid 41790912)
17. Lee DM, O'Neill TW, Pye SR et al (2009) The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 32:11-24
18. Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153-162 (Pubitemid 23092124)
19. Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737-2745 (Pubitemid 352008544)
20. Labrie F, Belanger A, Belanger P et al (2007) Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 103:178-188 (Pubitemid 46157181)
21. Labrie F, Belanger A, Belanger P et al (2006) Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182-188 (Pubitemid 43766081)
22. Van Pottelbergh I, Goemaere S, Kaufman JM (2003) Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88:3075-3081 (Pubitemid 36877475)
23. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
24. Pye SR, Devakumar V, Boonen S et al (2010) Influence of lifestyle factors on quantitative heel ultrasound measurements in middle-aged and elderly men. Calcif Tissue Int 86:211-219
25. Kurland ES, Rosen CJ, Cosman F et al (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799-2805 (Pubitemid 27385627)
26. Ohlsson C, Bengtsson BA, Isaksson OG et al (1998) Growth hormone and bone. Endocr Rev 19:55-79 (Pubitemid 29122074)
27. Rosen CJ, Donahue LR, Hunter SJ (1994) Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med 206:83-102 (Pubitemid 24188322)
28. Ebeling PR, Jones JD, O'Fallon WM et al (1993) Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387 (Pubitemid 23345501)
29. Grinspoon S, Baum H, Lee K et al (1996) Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864-3870 (Pubitemid 26380388)
30. Langlois JA, Rosen CJ, Visser M et al (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257-4262 (Pubitemid 29100118)
31. Bauer DC, Rosen C, Cauley J et al (1998) Low serum IGF-I but not IGFBP-3 predicts hip and spine fracture: the study of osteoporotic fracture. Bone 23(5 Suppl 1):S561
32. O'Neill TW, Marsden D, Matthis C et al (1995) Survey response rates: national and regional differences in a European multicentre study of vertebral osteoporosis. J Epidemiol Community Health 49:87-93
33. Feldman HA, Goldstein I, Hatzichristou DG et al (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61 (Pubitemid 24046934)